Response: Re: Age-Specific Evaluation of Primary Human Papillomavirus Screening vs Conventional Cytology in a Randomized Setting
Maarit K. Leinonen(University of Helsinki), Ahti Anttila(Finnish Cancer Registry), Jussi Tarkkanen, Nea Malila(Istituto Superiore di Sanità), Pekka Nieminen(University of Helsinki), P Laurila, Laura Kotaniemi‐Talonen
Cited by 0
Related Papers
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study
|The Lancet Oncology|2017|510
Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study
|European Journal of Cancer|2015|486
Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study
|The Lancet Oncology|2021|477
Survival of women with cancers of breast and genital organs in Europe 1999–2007: Results of the EUROCARE-5 study
|European Journal of Cancer|2015|279
Age-Specific Evaluation of Primary Human Papillomavirus Screening vs Conventional Cytology in a Randomized Setting
|JNCI Journal of the National Cancer Institute|2009|265